Predict your next investment

Venture Capital
cmcic-capitalfinance.com

See what CB Insights has to offer

Investments

56

Portfolio Exits

18

Funds

2

About Sudinnova

Subsidiary of Banque de Vizille, Sudinnova invests in fast growing startups. Advised by Vizille Capital Finance, Sudinnova co-invest with Vizille Capital Innovation in international companies focused on innovation. Sudinnova invests during seed stage as well as early or later stages.

Sudinnova Headquarter Location

Espace Cordeliers 2 rue Président Carnot

France

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sudinnova

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Sudinnova in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Sudinnova Investments

56 Investments

Sudinnova has made 56 investments. Their latest investment was in Universign as part of their Series A on November 11, 2013.

CBI Logo

Sudinnova Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/6/2013

Series A

Universign

$2.3M

Yes

CM-CIC Capital Finance

1

6/24/2013

Unattributed VC

Coldway

$12.18M

Yes

CDC Entreprises, CM-CIC Capital Finance, and Emertec Gestion

3

10/8/2012

Series B

EyeBrain

$4.3M

Yes

CM-CIC Capital Finance, G1J Ile-de-France, Karista, and Octalfa

1

5/10/2012

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

1/11/2011

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/6/2013

6/24/2013

10/8/2012

5/10/2012

1/11/2011

Round

Series A

Unattributed VC

Series B

Seed VC

Unattributed VC

Company

Universign

Coldway

EyeBrain

Subscribe to see more

Subscribe to see more

Amount

$2.3M

$12.18M

$4.3M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

CM-CIC Capital Finance

CDC Entreprises, CM-CIC Capital Finance, and Emertec Gestion

CM-CIC Capital Finance, G1J Ile-de-France, Karista, and Octalfa

Sources

1

3

1

10

10

Sudinnova Portfolio Exits

18 Portfolio Exits

Sudinnova has 18 portfolio exits. Their latest portfolio exit was EndoControl on June 12, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/12/2019

Acquired

Canady Life Sciences

2

11/12/2018

Acquired

Sofrigam

1

9/19/2016

Acq - Fin

ArchiMed

1

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

6/12/2019

11/12/2018

9/19/2016

00/00/0000

00/00/0000

Exit

Acquired

Acquired

Acq - Fin

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

Acquirer

Canady Life Sciences

Sofrigam

ArchiMed

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Sudinnova Fund History

2 Fund Histories

Sudinnova has 2 funds, including Sudinnova II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/1/2000

Sudinnova II

Multi-Stage Venture Capital

$28.69M

1

1/1/1983

Sudinnova

Subscribe to see more

$99M

10

Closing Date

9/1/2000

1/1/1983

Fund

Sudinnova II

Sudinnova

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Amount

$28.69M

$99M

Sources

1

10

Sudinnova Team

4 Team Members

Sudinnova has 4 team members, including current Chief Executive Officer, Rene Maury.

Name

Work History

Title

Status

Rene Maury

Chief Executive Officer

Current

Maury Rene

Chief Executive Officer

Current

Olivier Chiarisoli

Managing Director

Former

Pascal Demichel

Managing Director

Former

Name

Rene Maury

Maury Rene

Olivier Chiarisoli

Pascal Demichel

Work History

Title

Chief Executive Officer

Chief Executive Officer

Managing Director

Managing Director

Status

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.